PharmaCyte Biotech PMCB 深 滬
等待開盤 10-08 09:30:00 美东时间
0.4056
-0.017
-3.98%
華盛通- 最 高0.422
- 今 開0.417
- 成交量 9.75万股
- 最 低 0.4011
- 昨 收 0.4224
- 總市值 435.44万
- 52周最高 1.51
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 0.3339
- 委 比 0.00%
- 總股本 1073.56万
- 歷史最高 9.98
- 量 比 0.78
- 振 幅 4.95%
- 歷史最低 0.3339
- 每 手 1
- 風險率 0.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PharmaCyte Biotech Q1 EPS $(0.54) Up From $(1.23) YoY, Sales $0.00, Same YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(0.54) per share. This is a 56.1 percent increase over losses of $(1.23) per share from the same period last year. The company reported $0.00 in sales this quarter. This is the same as the same period last year.
09-15 05:03
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) stock increased by 12.5% to $3.11 during Mond...
05-19 05:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 23.3% to $0.16 during Tues...
03-11 05:06
PharmaCyte Biotech Delays Quarterly Report Filing
PharmaCyte Biotech ( ($PMCB) ) has released a notification of late filing. Phar...
2025-12-16 06:17
PharmaCyte Biotech Receives Noncompliance Notice From Nasdaq; Has Until June 2026 To Regain Compliance
On December 1, 2025, PharmaCyte Biotech, Inc. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the
2025-12-06 06:10
PharmaCyte Biotech Monetizes Femasys Stake; Cash And Securities Expected At ~$20M After Monetization, Up From $13.3M
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ:FEMY), further validating the Company's strategic approach to
2025-11-25 22:19
PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 percent decrease over earnings of $1.90 per share from the same period last year.
2025-09-16 05:01
PharmaCyte Biotech Invests Additional $3M In TNF Pharmaceuticals To Support LightSolver Partnership
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure TechnologiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB)
2025-09-02 21:22
PharmaCyte Biotech Secures $7 Million Private Placement
PharmaCyte Biotech ( ($PMCB) ) has issued an update. On August 17, 2025, Pharma...
2025-08-18 21:48
PharmaCyte Biotech Q4 EPS $1.54 Up From $(0.33) YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly earnings of $1.54 per share. This is a 566.67 percent increase over losses of $(0.33) per share from the same period last year.
2025-08-11 21:44
